November 20, 2019
  • November 20, 2019
Breaking News

Tag Archives

Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation

by on June 25, 2019 0
Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in discussions with the U.S. Federal Trade Commission (“FTC”) on the FTC’s continued review of the proposed transaction. To allow the transaction to close on a timely basis in light... Read More